Britten, Carolyn D.
Amgen Incorporated,
United States
2025 Rank: 168947
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 6235 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 168947 | 191022 |
| Total Cites | 5386 | 5683 |
| H-index | 35 | 36 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 273 | 276 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 1043 | 1093 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1402 | 1456 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5129 | 5394 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.05 |
| Self-Citation Percentage |
5.23%
|
|
Britten, Carolyn D.
Amgen Incorporated,
United States
2024 Rank: 166402
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 6215 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 166402 | 188550 |
| Total Cites | 5054 | 5334 |
| H-index | 33 | 34 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 264 | 267 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 1003 | 1046 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1337 | 1384 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4815 | 5065 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.05 |
| Self-Citation Percentage |
5.25%
|
|
Britten, Carolyn D.
Amgen Incorporated,
United States
2023 Rank: 165881
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 6250 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165881 | 185734 |
| Total Cites | 4713 | 4982 |
| H-index | 31 | 32 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 256 | 259 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 969 | 1010 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 1285 | 1329 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4490 | 4729 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.05 |
| Self-Citation Percentage |
5.40%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.